1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cholangitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Acute Cholangitis 1.2.3 Primary Sclerosing Cholangitis 1.2.4 Secondary Sclerosing Cholangitis 1.2.5 Recurrent Pyogenic Cholangitis 1.3 Market by Application 1.3.1 Global Cholangitis Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Clinical Practise 1.3.3 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cholangitis Market Perspective (2016-2027) 2.2 Cholangitis Growth Trends by Regions 2.2.1 Cholangitis Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cholangitis Historic Market Share by Regions (2016-2021) 2.2.3 Cholangitis Forecasted Market Size by Regions (2022-2027) 2.3 Cholangitis Industry Dynamic 2.3.1 Cholangitis Market Trends 2.3.2 Cholangitis Market Drivers 2.3.3 Cholangitis Market Challenges 2.3.4 Cholangitis Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cholangitis Players by Revenue 3.1.1 Global Top Cholangitis Players by Revenue (2016-2021) 3.1.2 Global Cholangitis Revenue Market Share by Players (2016-2021) 3.2 Global Cholangitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cholangitis Revenue 3.4 Global Cholangitis Market Concentration Ratio 3.4.1 Global Cholangitis Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cholangitis Revenue in 2020 3.5 Cholangitis Key Players Head office and Area Served 3.6 Key Players Cholangitis Product Solution and Service 3.7 Date of Enter into Cholangitis Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cholangitis Breakdown Data by Type 4.1 Global Cholangitis Historic Market Size by Type (2016-2021) 4.2 Global Cholangitis Forecasted Market Size by Type (2022-2027) 5 Cholangitis Breakdown Data by Application 5.1 Global Cholangitis Historic Market Size by Application (2016-2021) 5.2 Global Cholangitis Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cholangitis Market Size (2016-2027) 6.2 North America Cholangitis Market Size by Type 6.2.1 North America Cholangitis Market Size by Type (2016-2021) 6.2.2 North America Cholangitis Market Size by Type (2022-2027) 6.2.3 North America Cholangitis Market Size by Type (2016-2027) 6.3 North America Cholangitis Market Size by Application 6.3.1 North America Cholangitis Market Size by Application (2016-2021) 6.3.2 North America Cholangitis Market Size by Application (2022-2027) 6.3.3 North America Cholangitis Market Size by Application (2016-2027) 6.4 North America Cholangitis Market Size by Country 6.4.1 North America Cholangitis Market Size by Country (2016-2021) 6.4.2 North America Cholangitis Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Cholangitis Market Size (2016-2027) 7.2 Europe Cholangitis Market Size by Type 7.2.1 Europe Cholangitis Market Size by Type (2016-2021) 7.2.2 Europe Cholangitis Market Size by Type (2022-2027) 7.2.3 Europe Cholangitis Market Size by Type (2016-2027) 7.3 Europe Cholangitis Market Size by Application 7.3.1 Europe Cholangitis Market Size by Application (2016-2021) 7.3.2 Europe Cholangitis Market Size by Application (2022-2027) 7.3.3 Europe Cholangitis Market Size by Application (2016-2027) 7.4 Europe Cholangitis Market Size by Country 7.4.1 Europe Cholangitis Market Size by Country (2016-2021) 7.4.2 Europe Cholangitis Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Cholangitis Market Size (2016-2027) 8.2 Asia-Pacific Cholangitis Market Size by Type 8.2.1 Asia-Pacific Cholangitis Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Cholangitis Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Cholangitis Market Size by Type (2016-2027) 8.3 Asia-Pacific Cholangitis Market Size by Application 8.3.1 Asia-Pacific Cholangitis Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Cholangitis Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Cholangitis Market Size by Application (2016-2027) 8.4 Asia-Pacific Cholangitis Market Size by Region 8.4.1 Asia-Pacific Cholangitis Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Cholangitis Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cholangitis Market Size (2016-2027) 9.2 Latin America Cholangitis Market Size by Type 9.2.1 Latin America Cholangitis Market Size by Type (2016-2021) 9.2.2 Latin America Cholangitis Market Size by Type (2022-2027) 9.2.3 Latin America Cholangitis Market Size by Type (2016-2027) 9.3 Latin America Cholangitis Market Size by Application 9.3.1 Latin America Cholangitis Market Size by Application (2016-2021) 9.3.2 Latin America Cholangitis Market Size by Application (2022-2027) 9.3.3 Latin America Cholangitis Market Size by Application (2016-2027) 9.4 Latin America Cholangitis Market Size by Country 9.4.1 Latin America Cholangitis Market Size by Country (2016-2021) 9.4.2 Latin America Cholangitis Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cholangitis Market Size (2016-2027) 10.2 Middle East & Africa Cholangitis Market Size by Type 10.2.1 Middle East & Africa Cholangitis Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Cholangitis Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Cholangitis Market Size by Type (2016-2027) 10.3 Middle East & Africa Cholangitis Market Size by Application 10.3.1 Middle East & Africa Cholangitis Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Cholangitis Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Cholangitis Market Size by Application (2016-2027) 10.4 Middle East & Africa Cholangitis Market Size by Country 10.4.1 Middle East & Africa Cholangitis Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Cholangitis Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Taiho Pharmaceutical 11.1.1 Taiho Pharmaceutical Company Details 11.1.2 Taiho Pharmaceutical Business Overview 11.1.3 Taiho Pharmaceutical Cholangitis Introduction 11.1.4 Taiho Pharmaceutical Revenue in Cholangitis Business (2016-2021) 11.1.5 Taiho Pharmaceutical Recent Development 11.2 Mayo Clinic 11.2.1 Mayo Clinic Company Details 11.2.2 Mayo Clinic Business Overview 11.2.3 Mayo Clinic Cholangitis Introduction 11.2.4 Mayo Clinic Revenue in Cholangitis Business (2016-2021) 11.2.5 Mayo Clinic Recent Development 11.3 Bayer 11.3.1 Bayer Company Details 11.3.2 Bayer Business Overview 11.3.3 Bayer Cholangitis Introduction 11.3.4 Bayer Revenue in Cholangitis Business (2016-2021) 11.3.5 Bayer Recent Development 11.4 Gilead Sciences 11.4.1 Gilead Sciences Company Details 11.4.2 Gilead Sciences Business Overview 11.4.3 Gilead Sciences Cholangitis Introduction 11.4.4 Gilead Sciences Revenue in Cholangitis Business (2016-2021) 11.4.5 Gilead Sciences Recent Development 11.5 RiemserArzneimittel 11.5.1 RiemserArzneimittel Company Details 11.5.2 RiemserArzneimittel Business Overview 11.5.3 RiemserArzneimittel Cholangitis Introduction 11.5.4 RiemserArzneimittel Revenue in Cholangitis Business (2016-2021) 11.5.5 RiemserArzneimittel Recent Development 11.6 Zambon 11.6.1 Zambon Company Details 11.6.2 Zambon Business Overview 11.6.3 Zambon Cholangitis Introduction 11.6.4 Zambon Revenue in Cholangitis Business (2016-2021) 11.6.5 Zambon Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cholangitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Acute Cholangitis Table 3. Key Players of Primary Sclerosing Cholangitis Table 4. Key Players of Secondary Sclerosing Cholangitis Table 5. Key Players of Recurrent Pyogenic Cholangitis Table 6. Global Cholangitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Cholangitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Cholangitis Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Cholangitis Market Share by Regions (2016-2021) Table 10. Global Cholangitis Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Cholangitis Market Share by Regions (2022-2027) Table 12. Cholangitis Market Trends Table 13. Cholangitis Market Drivers Table 14. Cholangitis Market Challenges Table 15. Cholangitis Market Restraints Table 16. Global Cholangitis Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Cholangitis Market Share by Players (2016-2021) Table 18. Global Top Cholangitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholangitis as of 2020) Table 19. Ranking of Global Top Cholangitis Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Cholangitis Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Cholangitis Product Solution and Service Table 23. Date of Enter into Cholangitis Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Cholangitis Market Size by Type (2016-2021) (US$ Million) Table 26. Global Cholangitis Revenue Market Share by Type (2016-2021) Table 27. Global Cholangitis Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Cholangitis Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Cholangitis Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Cholangitis Revenue Market Share by Application (2016-2021) Table 31. Global Cholangitis Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Cholangitis Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Cholangitis Market Size by Type (2016-2021) (US$ Million) Table 34. North America Cholangitis Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Cholangitis Market Size by Application (2016-2021) (US$ Million) Table 36. North America Cholangitis Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Cholangitis Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Cholangitis Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Cholangitis Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Cholangitis Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Cholangitis Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Cholangitis Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Cholangitis Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Cholangitis Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Cholangitis Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Cholangitis Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Cholangitis Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Cholangitis Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Cholangitis Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Cholangitis Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Cholangitis Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Cholangitis Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Cholangitis Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Cholangitis Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Cholangitis Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Cholangitis Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Cholangitis Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Cholangitis Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Cholangitis Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Cholangitis Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Cholangitis Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Cholangitis Market Size by Country (2022-2027) & (US$ Million) Table 63. Taiho Pharmaceutical Company Details Table 64. Taiho Pharmaceutical Business Overview Table 65. Taiho Pharmaceutical Cholangitis Product Table 66. Taiho Pharmaceutical Revenue in Cholangitis Business (2016-2021) & (US$ Million) Table 67. Taiho Pharmaceutical Recent Development Table 68. Mayo Clinic Company Details Table 69. Mayo Clinic Business Overview Table 70. Mayo Clinic Cholangitis Product Table 71. Mayo Clinic Revenue in Cholangitis Business (2016-2021) & (US$ Million) Table 72. Mayo Clinic Recent Development Table 73. Bayer Company Details Table 74. Bayer Business Overview Table 75. Bayer Cholangitis Product Table 76. Bayer Revenue in Cholangitis Business (2016-2021) & (US$ Million) Table 77. Bayer Recent Development Table 78. Gilead Sciences Company Details Table 79. Gilead Sciences Business Overview Table 80. Gilead Sciences Cholangitis Product Table 81. Gilead Sciences Revenue in Cholangitis Business (2016-2021) & (US$ Million) Table 82. Gilead Sciences Recent Development Table 83. RiemserArzneimittel Company Details Table 84. RiemserArzneimittel Business Overview Table 85. RiemserArzneimittel Cholangitis Product Table 86. RiemserArzneimittel Revenue in Cholangitis Business (2016-2021) & (US$ Million) Table 87. RiemserArzneimittel Recent Development Table 88. Zambon Company Details Table 89. Zambon Business Overview Table 90. Zambon Cholangitis Product Table 91. Zambon Revenue in Cholangitis Business (2016-2021) & (US$ Million) Table 92. Zambon Recent Development Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Cholangitis Market Share by Type: 2020 VS 2027 Figure 2. Acute Cholangitis Features Figure 3. Primary Sclerosing Cholangitis Features Figure 4. Secondary Sclerosing Cholangitis Features Figure 5. Recurrent Pyogenic Cholangitis Features Figure 6. Global Cholangitis Market Share by Application: 2020 VS 2027 Figure 7. Clinical Practise Case Studies Figure 8. Others Case Studies Figure 9. Cholangitis Report Years Considered Figure 10. Global Cholangitis Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Cholangitis Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Cholangitis Market Share by Regions: 2020 VS 2027 Figure 13. Global Cholangitis Market Share by Regions (2022-2027) Figure 14. Global Cholangitis Market Share by Players in 2020 Figure 15. Global Top Cholangitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholangitis as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Cholangitis Revenue in 2020 Figure 17. Global Cholangitis Revenue Market Share by Type (2016-2021) Figure 18. Global Cholangitis Revenue Market Share by Type (2022-2027) Figure 19. North America Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Cholangitis Market Share by Type (2016-2027) Figure 21. North America Cholangitis Market Share by Application (2016-2027) Figure 22. North America Cholangitis Market Share by Country (2016-2027) Figure 23. United States Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Cholangitis Market Share by Type (2016-2027) Figure 27. Europe Cholangitis Market Share by Application (2016-2027) Figure 28. Europe Cholangitis Market Share by Country (2016-2027) Figure 29. Germany Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Cholangitis Market Share by Type (2016-2027) Figure 37. Asia-Pacific Cholangitis Market Share by Application (2016-2027) Figure 38. Asia-Pacific Cholangitis Market Share by Region (2016-2027) Figure 39. China Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Cholangitis Market Share by Type (2016-2027) Figure 47. Latin America Cholangitis Market Share by Application (2016-2027) Figure 48. Latin America Cholangitis Market Share by Country (2016-2027) Figure 49. Mexico Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Cholangitis Market Share by Type (2016-2027) Figure 53. Middle East & Africa Cholangitis Market Share by Application (2016-2027) Figure 54. Middle East & Africa Cholangitis Market Share by Country (2016-2027) Figure 55. Turkey Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Taiho Pharmaceutical Revenue Growth Rate in Cholangitis Business (2016-2021) Figure 59. Mayo Clinic Revenue Growth Rate in Cholangitis Business (2016-2021) Figure 60. Bayer Revenue Growth Rate in Cholangitis Business (2016-2021) Figure 61. Gilead Sciences Revenue Growth Rate in Cholangitis Business (2016-2021) Figure 62. RiemserArzneimittel Revenue Growth Rate in Cholangitis Business (2016-2021) Figure 63. Zambon Revenue Growth Rate in Cholangitis Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Taiho Pharmaceutical Mayo Clinic Bayer Gilead Sciences RiemserArzneimittel Zambon